[The use of ticagrelor in acute coronary syndromes]
Sinan Aydoğdu1, Özlem Özcan Çelebi
1Türkiye Yüksek Ihtisas Hastanesi Kardiyoloji KIiniği, Ankara. sinanaydogdu@yahoo.com
Abstract:
Acute coronary syndrome plays a major role in the treatment of acute coronary syndrome. New agents have been developed and introduced into clinical practice while dual antiplattelet therapy has been limited with clopidogrel until recently. In this review we summarize the efficacy of ticagrelor, a new antiplatelet agent.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome V: Nursing Management


